2025. 23. SYSTEMATIC REVIEW OF THE COST - EFFECTIVENESS OF PEMBROLIZUMAB IN RECURRENT OR METASTATIC CERVICAL CANCER. Vietnam Journal of Community Medicine. 66, CĐ8-NCKH (Aug. 2025). DOI:https://doi.org/10.52163/yhc.v66iCD8.2569.